News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Skyhawk Therapeutics Launches Cutting-Edge Laboratories in Basel, Switzerland
Thursday, June 27, 2024Skyhawk Therapeutics Inc a clinicalstage biotech company focused on developing innovative small molecule therapies that target critical RNA molecules has announced its expansion
InDevR Introduces 5'CapQ for Quick Assessment of mRNA Vaccine Quality Attributes
Wednesday, June 26, 2024InDevR Inc a leader in vaccine analytical solutions has introduced CapQ a new kit designed for rapid determination of mRNA capping efficiency This solution part of the VaxArray Platform
ProBio Expands Plasmid DNA and Viral Vector Production Facility in New Jersey to Speed Up Delivery of Cell and Gene Therapies
Wednesday, June 26, 2024ProBio Inc a prominent contract development and manufacturing organization based in New Jersey has inaugurated a stateoftheart facility in Hopewell New Jersey aimed at expanding its capabilities
Navamedic and Orion Corporation Form License & Supply Agreement for Flexilev® in Europe
Tuesday, June 25, 2024Navamedic ASA and Orion Corporation have signed an exclusive license and supply agreement for Flexilev and its OraFID dispenser in most of Europe excluding Sweden Norway Denmark and Iceland
TOFIDENCE™, a Biosimilar of ROACTEMRA® (Tocilizumab), Receives Approval in the European Union
Tuesday, June 25, 2024Biogen Inc has received approval from the European Commission for TOFIDENCE a biosimilar monoclonal antibody referencing ROACTEMRA This intravenous formulation
FDA Grants IND Approval for First Gene Therapy Targeting Common Neurological Conditions – EG 427 Commences Initial Human Clinical Trial
Monday, June 24, 2024EG a leading biotechnology company has received FDA clearance for clinical trials of EGA a gene therapy targeting Neurogenic Bladder NDO in spinal cord injury SCI patients This therapy utilizes
AriBio Co., Ltd. and Kentucky Clinical Trial Laboratory (KCTL) Collaborate to Expand Alzheimer’s Disease Testing
Saturday, June 22, 2024AriBio Co Ltd has announced a strategic collaboration with Kentucky Clinical Trial Laboratory to expand Alzheimers disease testing This partnership focuses on utilizing the Lumipulse system from FujireBio
FDA Approves Expansion of Gene Therapy for Duchenne Muscular Dystrophy
Friday, June 21, 2024The US Food and Drug Administration recently expanded its approval of Elevidys a gene therapy for Duchenne muscular dystrophy to include ambulatory and nonambulatory individuals aged years and older with a confirmed mutation in the DMD gene Initiall...
C-Path and CENTOGENE Enhance Collaboration in Advancing Lysosomal Disease Research and Drug Development
Friday, June 21, 2024The Critical Path Institute and Centogene NV have entered into a Memorandum of Understanding to collaborate on advancing drug development for lysosomal diseases and enhancing the quality
Abzena and Argonaut Collaborate to Enhance Support for Biopharmaceutical Drug Development
Friday, June 21, 2024Abzena a prominent contract development and manufacturing organization specializing in complex biologics and bioconjugates has formed a strategic partnership
